The travel diaries of tetanus and botulinum neurotoxins

Toxicon

Volumn 147, Issue , 2018, Pages 58-67

  Surana, Sunaina ^a   Tosolini, Andrew P ^a   Meyer, Ione F G ^a,b   Fellows, Alexander D ^a   Novoselov, Sergey S ^a   Schiavo, Giampietro ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Axonal retrograde transport; Botulinum neurotoxin; Clostridial neurotoxin; Endocytosis; Neuromuscular junction; Tetanus toxin

Indexed keywords

BOTULINUM TOXIN; FIBROBLAST GROWTH FACTOR 3; MEMBRANE RECEPTOR; POLYSIALOGANGLIOSIDE; SNARE PROTEIN; SPHINGOLIPID; SYNAPTOBREVIN; UNCLASSIFIED DRUG; TETANUS TOXIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; BOTULISM; CELL VACUOLE; ENDOSOME; EXOCYTOSIS; HUMAN; LETHAL DOSE; MOTONEURON; NERVE CELL; NERVE FIBER TRANSPORT; NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SYNAPTIC TRANSMISSION; TETANUS; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; BOTULINUM TOXINS; HUMANS; PROTEIN TRANSPORT; TETANUS TOXIN;

EID: 85031720890     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2017.10.008     Document Type: Article

References (151)

1. Amatsu, S., Sugawara, Y., Matsumura, T., Kitadokoro, K., Fujinaga, Y., Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex. J. Biol. Chem. 288 (2013), 35617–35625.
2. Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O., Caleo, M., Long-distance retrograde effects of botulinum neurotoxin A. J. Neurosci. 28 (2008), 3689–3696.
3. Azarnia Tehran, D., Pirazzini, M., Leka, O., Mattarei, A., Lista, F., Binz, T., Rossetto, O., Montecucco, C., Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals. Cell. Microbiol., 19(2), 2017 Feb, 10.1111/cmi.12647 Epub 2016 Aug 4.
4. Bagetta, G., Knott, C., Nistico, G., Bowery, N.G., Tetanus toxin produces neuronal loss and a reduction in GABAA but not GABAB binding sites in rat hippocampus. Neurosci. Lett. 109 (1990), 7–12.
5. Baldwin, M.R., Barbieri, J.T., Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry 46 (2007), 3200–3210.
6. Behzadi, E., Halabian, R., Hosseini, H.M., Fooladi, A.A., Bacterial toxin's DNA vaccine serves as a strategy for the treatment of cancer, infectious and autoimmune diseases. Microb. Pathog. 100 (2016), 184–194.
7. Bercsenyi, K., et al. Tetanus toxin entry. Nidogens are therapeutic targets for the prevention of tetanus. Science 346 (2014), 1118–1123.
8. Bergey, G.K., Bigalke, H., Nelson, P.G., Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin. J. Neurophysiol 57 (1987), 121–131.
9. Bhattacharyya, S.D., Sugiyama, H., Inactivation of botulinum and tetanus toxins by chelators. Infect. Immun. 57 (1989), 3053–3057.
10. Bigalke, H., Muller, H., Dreyer, F., Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structure. Toxicon 24 (1986), 1065–1074.
11. Bilsland, L.G., Sahai, E., Kelly, G., Golding, M., Greensmith, L., Schiavo, G., Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 20523–20528.
12. Black, J.D., Dolly, J.O., Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J. Cell Biol. 103 (1986), 521–534.
13. Blum, F.C., Chen, C., Kroken, A.R., Barbieri, J.T., Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Infect. Immun. 80 (2012), 1662–1669.
14. Blum, F.C., Tepp, W.H., Johnson, E.A., Barbieri, J.T., Multiple domains of tetanus toxin direct entry into primary neurons. Traffic 15 (2014), 1057–1065.
15. Bohnert, S., Schiavo, G., Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. J. Biol. Chem. 280 (2005), 42336–42344.
16. Bomba-Warczak, E., Vevea, J.D., Brittain, J.M., Figueroa-Bernier, A., Tepp, W.H., Johnson, E.A., Yeh, F.L., Chapman, E.R., Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons. Cell Rep. 16 (2016), 1974–1987.
17. Bordet, T., Castelnau-Ptakhine, L., Fauchereau, F., Friocourt, G., Kahn, A., Haase, G., Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment. Mol. Cell. Neurosci. 17 (2001), 842–854.
18. Bowery, N.G., Bagetta, G., Nistico, G., Britton, P., Whitton, P., Intrahippocampal tetanus toxin produces generalized convulsions and neurodegeneration in rats: antagonism by NMDA receptor blockers. Epilepsy Res. Suppl. 9 (1992), 249–256.
19. Breidenbach, M.A., Brunger, A.T., 2.3 A crystal structure of tetanus neurotoxin light chain. Biochemistry 44 (2005), 7450–7457.
20. Caleo, M., Schiavo, G., Central effects of tetanus and botulinum neurotoxins. Toxicon 54 (2009), 593–599.
21. Calvo, A.C., et al. Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule. Orphanet J. Rare Dis., 6, 2011, 10.
22. Carlton, E., Teng, Q., Federici, T., Yang, J., Riley, J., Boulis, N.M., Fusion of the tetanus toxin C fragment binding domain and Bcl-xL for protection of peripheral nerve neurons. Neurosurgery 63 (2008), 1175–1184.
23. Carter, A.P., Diamant, A.G., Urnavicius, L., How dynein and dynactin transport cargos: a structural perspective. Curr. Opin. Struct. Biol. 37 (2016), 62–70.
24. Charlier, C.M., Debaisieux, S., Foret, C., Thouard, A., Schiavo, G., Gonzalez-Dunia, D., Malnou, C.E., Neuronal retrograde transport of Borna disease virus occurs in signalling endosomes. J. Gen. Virol. 97 (2016), 3215–3224.
25. Chen, C., Fu, Z.J., Kim, J.J.P., Barbieri, J.T., Baldwin, M.R., Gangliosides as high affinity receptors for tetanus neurotoxin. J. Biol. Chem. 284 (2009), 26569–26577.
26. Ciriza, J., et al. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model. Restor. Neurol. Neurosci. 26 (2008), 459–465.
27. Coen, L., Kissa, K., le Mevel, S., Brulet, P., Demeneix, B.A., A somatic gene transfer approach using recombinant fusion proteins to map muscle-motoneuron projections in Xenopus spinal cord. Int. J. Dev. Biol. 43 (1999), 823–830.
28. Coen, L., Osta, R., Maury, M., Brulet, P., Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 9400–9405.
29. Cordero-Erausquin, M., Allard, S., Dolique, T., Bachand, K., Ribeiro-da-Silva, A., De Koninck, Y., Dorsal horn neurons presynaptic to lamina I spinoparabrachial neurons revealed by transynaptic labeling. J. Comp. Neurol. 517 (2009), 601–615.
30. de Paiva, A., Poulain, B., Lawrence, G.W., Shone, C.C., Tauc, L., Dolly, J.O., A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly. J. Biol. Chem. 268 (1993), 20838–20844.
31. De Vos, K.J., Hafezparast, M., Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research?. Neurobiol. Dis., 2017, 10.1016/j.nbd.2017.1002.1004.
32. Debaisieux, S., Encheva, V., Chakravarty, P., Snijders, A.P., Schiavo, G., Analysis of signaling endosome composition and dynamics using SILAC in embryonic stem cell-derived neurons. Mol. Cell. Proteom. 15 (2016), 542–557.
33. Deinhardt, K., Berninghausen, O., Willison, H.J., Hopkins, C.R., Schiavo, G., Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin 1. J. Cell Biol. 174 (2006), 459–471.
34. Deinhardt, K., Salinas, S., Verastegui, C., Watson, R., Worth, D., Hanrahan, S., Bucci, C., Schiavo, G., Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52 (2006), 293–305.
35. Fan, C., Chu, X., Wang, L., Shi, H., Li, T., Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain. Toxicon 133 (2017), 116–122.
36. Ferecsko, A.S., Jiruska, P., Foss, L., Powell, A.D., Chang, W.C., Sik, A., Jefferys, J.G., Structural and functional substrates of tetanus toxin in an animal model of temporal lobe epilepsy. Brain Struct. Funct. 220 (2015), 1013–1029.
37. Ferrari, E., et al. Synthetic self-assembling clostridial chimera for modulation of sensory functions. Bioconjug. Chem. 24 (2013), 1750–1759.
38. Francis, J.W., Bastia, E., Matthews, C.C., Parks, D.A., Schwarzschild, M.A., Brown, R.H. Jr., Fishman, P.S., Tetanus toxin fragment C as a vector to enhance delivery of proteins to the CNS. Brain Res. 1011 (2004), 7–13.
39. Francis, J.W., et al. A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons. Brain Res. 995 (2004), 84–96.
40. Garcia-Rodriguez, C., Levy, R., Arndt, J.W., Forsyth, C.M., Razai, A., Lou, J., Geren, I., Stevens, R.C., Marks, J.D., Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat. Biotechnol. 25 (2007), 107–116.
41. Gil, C., Chaib-Oukadour, I., Aguilera, J., C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons. Biochem. J. 373 (2003), 613–620.
42. Gil, C., Chaib-Oukadour, I., Blasi, J., Aguilera, J., HC fragment (C-terminal portion of the heavy chain) of tetanus toxin activates protein kinase C isoforms and phosphoproteins involved in signal transduction. Biochem. J. 356 (2001), 97–103.
43. Gill, D.M., Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 46 (1982), 86–94.
44. Goldstein, L.S., Yang, Z., Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu. Rev. Neurosci. 23 (2000), 39–71.
45. Gu, S., Rumpel, S., Zhou, J., Strotmeier, J., Bigalke, H., Perry, K., Shoemaker, C.B., Rummel, A., Jin, R., Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 335 (2012), 977–981.
46. Habermann, E., Clostridial neurotoxins and the central nervous system: functional studies on isolated preparations. Simpson, L.L., (eds.) Botulinum Neurotoxins and Tetanus Toxin, 1989, Academic Press, San Diego.
47. Habermann, E., Erdmann, G., Pharmacokinetic and histoautoradiographic evidence for the intraaxonal movement of toxin in the pathogenesis of tetanus. Toxicon 16 (1978), 611–623.
48. Hafezparast, M., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003), 808–812.
49. Harper, C.B., et al. Dynamin inhibition blocks botulinum neurotoxin type a endocytosis in neurons and delays botulism. J. Biol. Chem. 286 (2011), 35966–35976.
50. Harper, C.B., et al. Botulinum neurotoxin type-A enters a non-recycling pool of synaptic vesicles. Sci. Rep., 6, 2016, 19654.
51. Haugsten, E.M., Zakrzewska, M., Brech, A., Pust, S., Olsnes, S., Sandvig, K., Wesche, J., Clathrin- and dynamin-independent endocytosis of FGFR3-implications for signalling. PLoS One, 6, 2011, e21708.
52. Herreros, J., Ng, T., Schiavo, G., Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons., 12, 2001, 2947–2960.
53. Hirokawa, N., Niwa, S., Tanaka, Y., Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 68 (2010), 610–638.
54. Hislop, J.N., Islam, T.A., Eleftheriadou, I., Carpentier, D.C., Trabalza, A., Parkinson, M., Schiavo, G., Mazarakis, N.D., Rabies virus envelope glycoprotein targets lentiviral vectors to the axonal retrograde pathway in motor neurons. J. Biol. Chem. 289 (2014), 16148–16163.
55. Hong, B., Yao, L., Ni, L., Wang, L., Hu, X., Antinociceptive effect of botulinum toxin A involves alterations in AMPA receptor expression and glutamate release in spinal dorsal horn neurons. Neuroscience 357 (2017), 197–207.
56. Hoogenraad, C.C., Akhmanova, A., Bicaudal D family of motor adaptors: linking dynein motility to cargo binding. Trends Cell Biol. 26 (2016), 327–340.
57. Jacky, B.P., et al. Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A). PLoS Pathog., 9, 2013, e1003369.
58. Karalewitz, A.P., Fu, Z., Baldwin, M.R., Kim, J.J., Barbieri, J.T., Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. J. Biol. Chem. 287 (2012), 40806–40816.
59. Kitamura, M., Igimi, S., Furukawa, K., Furukawa, K., Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins. Biochim. Biophys. Acta 1741 (2005), 1–3.
60. Kitamura, M., Iwamori, M., Nagai, Y., Interaction between Clostridium botulinum neurotoxin and gangliosides. Biochim. Biophys. Acta 628 (1980), 328–335.
61. Kumar, D., Boehm, U., Conditional genetic transsynaptic tracing in the embryonic mouse brain. J. Vis. Exp., 2014, 10.3791/52487.
62. Kumaran, D., Eswaramoorthy, S., Furey, W., Navaza, J., Sax, M., Swaminathan, S., Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J. Mol. Biol. 386 (2009), 233–245.
63. Lacy, D.B., Stevens, R.C., Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291 (1999), 1091–1104.
64. Lacy, D.B., Tepp, W., Cohen, A.C., DasGupta, B.R., Stevens, R.C., Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5 (1998), 898–902.
65. Lalli, G., Bohnert, S., Deinhardt, K., Verastegui, C., Schiavo, G., The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol. 11 (2003), 431–437.
66. Lalli, G., Herreros, J., Osborne, S.L., Montecucco, C., Rossetto, O., Schiavo, G., Functional characterisation of tetanus and botulinum neurotoxins binding domains. J. Cell Sci. 112 (1999), 2715–2724.
67. NTR. J. Cell Biol. 156 (2002), 233–239.
68. Larsen, K.E., et al. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice. Brain Res. 1120 (2006), 1–12.
69. Lawrence, G.W., Ovsepian, S.V., Wang, J., Aoki, K.R., Dolly, J.O., Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmission. Biochem. J. 441 (2012), 443–452.
70. Lee, K., et al. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog., 9, 2013, e1003690.
71. Lee, K., Zhong, X., Gu, S., Kruel, A.M., Dorner, M.B., Perry, K., Rummel, A., Dong, M., Jin, R., Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344 (2014), 1405–1410.
72. LeRoux, L.G., Bredow, S., Grosshans, D., Schellingerhout, D., Molecular imaging detects impairment in the retrograde axonal transport mechanism after radiation-induced spinal cord injury. Mol. Imaging Biol. 16 (2014), 504–510.
73. Malik, B., Nirmalananthan, N., Bilsland, L.G., La Spada, A.R., Hanna, M.G., Schiavo, G., Gallo, J.M., Greensmith, L., Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 20 (2011), 1776–1786.
74. Mangione, A.S., Obara, I., Maiaru, M., Geranton, S.M., Tassorelli, C., Ferrari, E., Leese, C., Davletov, B., Hunt, S.P., Nonparalytic botulinum molecules for the control of pain. Pain 157 (2016), 1045–1055.
75. Marie, A., Recherche sur la toxine tetanique. Ann. Inst. Past. 11 (1897), 591–599.
76. Masuyer, G., Conrad, J., Stenmark, P., The structure of the tetanus toxin reveals pH-mediated domain dynamics. EMBO Rep. 18 (2017), 1306–1317.
77. Matak, I., Rossetto, O., Lackovic, Z., Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons. Pain 155 (2014), 1516–1526.
78. Matsuda, M., Sugimoto, N., Ozutsumi, K., Hirai, T., Acute botulinum-like intoxication by tetanus neurotoxin in mice. Biochem. Biophys. Res. Comm. 104 (1982), 799–805.
79. Matteoli, M., Verderio, C., Rossetto, O., Iezzi, N., Coco, S., Schiavo, G., Montecucco, C., Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 13310–13315.
80. Mazzocchio, R., Caleo, M., More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system. Neuroscientist 21 (2015), 44–61.
81. McMahon, H.T., Foran, P., Dolly, J.O., Verhage, M., Wiegant, V.M., Nicholls, D.G., Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action. J. Biol. Chem. 267 (1992), 21338–21343.
82. Mendieta, L., Venegas, B., Moreno, N., Patricio, A., Martinez, I., Aguilera, J., Limon, I.D., The carboxyl-terminal domain of the heavy chain of tetanus toxin prevents dopaminergic degeneration and improves motor behavior in rats with striatal MPP(+)-lesions. Neurosci. Res. 65 (2009), 98–106.
83. Miana-Mena, F.J., Munoz, M.J., Ciriza, J., Soria, J., Brulet, P., Zaragoza, P., Osta, R., Fragment C tetanus toxin: a putative activity-dependent neuroanatomical tracer. Acta Neurobiol. Exp. (Wars.) 63 (2003), 211–218.
84. Montal, M., Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 79 (2010), 591–617.
85. Montecucco, C., How do tetanus and botulinum toxins bind to neuronal membranes. Trends Biochem. Sci. 11 (1986), 315–317.
86. Montecucco, C., Rossetto, O., Schiavo, G., Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 12 (2004), 442–446.
87. Montecucco, C., Schiavo, G., Pantano, S., SNARE complexes and neuroexocytosis: how many, how close?. Trends Biochem. Sci. 30 (2005), 367–372.
88. Moreno-Igoa, M., Calvo, A.C., Ciriza, J., Munoz, M.J., Zaragoza, P., Osta, R., Non-viral gene delivery of the GDNF, either alone or fused to the C-fragment of tetanus toxin protein, prolongs survival in a mouse ALS model. Restor. Neurol. Neurosci. 30 (2012), 69–80.
89. Moreno-Igoa, M., et al. Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy. J. Mol. Med. (Berl.) 88 (2010), 297–308.
90. Muraro, L., Tosatto, S., Motterlini, L., Rossetto, O., Montecucco, C., The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane. Biochem. Biophys. Res. Commun. 380 (2009), 76–80.
91. Oates, E.C., et al. Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am. J. Hum. Genet. 92 (2013), 965–973.
92. Ohka, S., Sakai, M., Bohnert, S., Igarashi, H., Deinhardt, K., Schiavo, G., Nomoto, A., Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J. Virol. 83 (2009), 4995–5004.
93. Olivan, S., Calvo, A.C., Rando, A., Herrando-Grabulosa, M., Manzano, R., Zaragoza, P., Tizzano, E.F., Aquilera, J., Osta, R., Neuroprotective effect of non-viral gene therapy treatment based on tetanus toxin C-fragment in a severe mouse model of spinal muscular atrophy. Front. Mol. Neurosci., 9, 2016, 76.
94. Oliveira, H., Fernandez, R., Pires, L.R., Martins, M.C., Simoes, S., Barbosa, M.A., Pego, A.P., Targeted gene delivery into peripheral sensorial neurons mediated by self-assembled vectors composed of poly(ethylene imine) and tetanus toxin fragment c. J. Control. Release 143 (2010), 350–358.
95. Ovsepian, S.V., Bodeker, M., O'Leary, V.B., Lawrence, G.W., Oliver Dolly, J., Internalization and retrograde axonal trafficking of tetanus toxin in motor neurons and trans-synaptic propagation at central synapses exceed those of its C-terminal-binding fragments. Brain Struct. Funct. 220 (2015), 1825–1838.
96. Papagiannopoulou, D., Vardouli, L., Dimitriadis, F., Apostolidis, A., Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats. BJU Int. 117 (2016), 697–704.
97. Peck, M.W., et al. Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature. Toxins (Basel), 9, 2017, 10.3390/toxins9010038.
98. Pirazzini, M., Azarnia Tehran, D., Leka, O., Zanetti, G., Rossetto, O., Montecucco, C., On the translocation of botulinum and tetanus neurotoxins across the membrane of acidic intracellular compartments. Biochim. Biophys. Acta 1858 (2016), 467–474.
99. Pirazzini, M., Azarnia Tehran, D., Zanetti, G., Lista, F., Binz, T., Shone, C.C., Rossetto, O., Montecucco, C., The thioredoxin reductase–Thioredoxin redox system cleaves the interchain disulphide bond of botulinum neurotoxins on the cytosolic surface of synaptic vesicles. Toxicon 107 (2015), 32–36.
100. Pirazzini, M., et al. Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins. Cell Rep. 8 (2014), 1870–1878.
101. Pirazzini, M., Rossetto, O., Eleopra, R., Montecucco, C., Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol. Rev. 69 (2017), 200–235.
102. Restani, L., Giribaldi, F., Manich, M., Bercsenyi, K., Menendez, G., Rossetto, O., Caleo, M., Schiavo, G., Botulinum neurotoxins A and E Undergo retrograde axonal transport in primary motor neurons. PLoS Pathog., 8, 2012, e1003087.
103. Restani, L., Novelli, E., Bottari, D., Leone, P., Barone, I., Galli-Resta, L., Strettoi, E., Caleo, M., Botulinum neurotoxin a impairs neurotransmission following retrograde transynaptic transport. Traffic 13 (2012), 1083–1089.
104. Rinaldi, S., Brennan, K.M., Goodyear, C.S., O'Leary, C., Schiavo, G., Crocker, P.R., Willison, H.J., Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology 19 (2009), 789–796.
105. Rossetto, O., Seveso, M., Caccin, P., Schiavo, G., Montecucco, C., Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon 39 (2001), 27–41.
106. Rossor, A.M., et al. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2. Brain 138 (2015), 293–310.
107. Roux, S., Saint Cloment, C., Curie, T., Girard, E., Mena, F.J., Barbier, J., Osta, R., Molgo, J., Brulet, P., Brain-derived neurotrophic factor facilitates in vivo internalization of tetanus neurotoxin C-terminal fragment fusion proteins in mature mouse motor nerve terminals. Eur. J. Neurosci. 24 (2006), 1546–1554.
108. Rummel, A., Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr. Top. Microbiol. Immunol. 364 (2013), 61–90.
109. Rummel, A., Two feet on the membrane: uptake of clostridial neurotoxins. Curr. Top. Microbiol. Immunol., 2016.
110. CC-domain of tetanus neurotoxin are required for toxicity. J. Mol. Biol. 326 (2003), 835–847.
111. Rummel, A., et al. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 359–364.
112. Rummel, A., et al. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J. Neurochem. 110 (2009), 1942–1954.
113. Salinas, S., Bilsland, L.G., Henaff, D., Weston, A.E., Keriel, A., Schiavo, G., Kremer, E.J., CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog., 5, 2009, e1000442.
114. Schafer, M.K., Bellouze, S., Jacquier, A., Schaller, S., Richard, L., Mathis, S., Vallat, J.M., Haase, G., Sensory neuropathy in progressive motor neuronopathy (pmn) mice is associated with defects in microtubule polymerization and axonal transport. Brain Pathol. 27 (2017), 459–471.
115. Schiavo, G., Greensmith, L., Hafezparast, M., Fisher, E.M., Cytoplasmic dynein heavy chain: the servant of many masters. Trends Neurosci. 36 (2013), 641–651.
116. Schiavo, G., Papini, E., Genna, G., Montecucco, C., An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin. Infect. Immun. 58 (1990), 4136–4141.
117. Schiavo, G., Poulain, B., Rossetto, O., Benfenati, F., Tauc, L., Montecucco, C., Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J. 11 (1992), 3577–3583.
118. Schiavo, G., Rossetto, O., Santucci, A., DasGupta, B.R., Montecucco, C., Botulinum neurotoxins are zinc proteins. J. Biol. Chem. 267 (1992), 23479–23483.
119. Schiavo, G., Shone, C.C., Bennett, M.K., Scheller, R.H., Montecucco, C., Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270 (1995), 10566–10570.
120. Schiavo, G., Shone, C.C., Rossetto, O., Alexander, F.C., Montecucco, C., Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268 (1993), 11516–11519.
121. Schmieg, N., Menendez, G., Schiavo, G., Terenzio, M., Signalling endosomes in axonal transport: travel updates on the molecular highway. Semin. Cell Dev. Biol. 27 (2014), 32–43.
122. Schmitt, A., Dreyer, F., John, C., At least three sequential steps are involved in the tetanus toxin-induced block of neuromuscular transmission. Naunyn Schmiedeb. Arch. Pharmacol. 317 (1981), 326–330.
123. Shin, M.C., Nonaka, K., Wakita, M., Yamaga, T., Torii, Y., Harakawa, T., Ginnaga, A., Ito, Y., Akaike, N., Effects of tetanus toxin on spontaneous and evoked transmitter release at inhibitory and excitatory synapses in the rat SDCN neurons. Toxicon 59 (2012), 385–392.
124. Simpson, L.L., Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie 82 (2000), 943–953.
125. Sleigh, J.N., Schiavo, G., Older but not slower: Aging does not alter axonal transport dynamics of signalling endosomes in vivo. Matters, 2016, 10.19185/matters.201605000018.
126. Sleigh, J.N., et al. Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations. Proc. Natl. Acad. Sci. U. S. A. 114 (2017), E3324–E3333.
127. Sleigh, J.N., Vagnoni, A., Twelvetrees, A.E., Schiavo, G., Methodological advances in imaging intravital axonal transport. F1000Res., 6, 2017, 200.
128. Stevens, R.C., Evenson, M.L., Tepp, W., DasGupta, B.R., Crystallization and preliminary X-ray analysis of botulinum neurotoxin type A. J. Mol. Biol. 222 (1991), 877–880.
129. Stoeckel, K., Schwab, M., Thoenen, H., Role of gangliosides in the uptake and retrograde axonal transport of cholera and tetanus toxin as compared to nerve growth factor and wheat germ agglutinin. Brain Res. 132 (1977), 273–285.
130. Sugawara, Y., Yutani, M., Amatsu, S., Matsumura, T., Fujinaga, Y., Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and e-cadherin binding sites. PLoS One, 9, 2014, e111170.
131. Swaminathan, S., Eswaramoorthy, S., Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 7 (2000), 693–699.
132. Takamizawa, K., Iwamori, M., Kozaki, S., Sakaguchi, G., Tanaka, R., Takayama, H., Nagai, Y., TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids. FEBS Lett. 201 (1986), 229–232.
133. Terenzio, M., Golding, M., Russell, M.R., Wicher, K.B., Rosewell, I., Spencer-Dene, B., Ish-Horowicz, D., Schiavo, G., Bicaudal-D1 regulates the intracellular sorting and signalling of neurotrophin receptors. EMBO J. 33 (2014), 1582–1598.
134. Terenzio, M., Golding, M., Schiavo, G., siRNA screen of ES cell-derived motor neurons identifies novel regulators of tetanus toxin and neurotrophin receptor trafficking. Front. Cell. Neurosci., 8, 2014, 140.
135. Toivonen, J.M., Olivan, S., Osta, R., Tetanus toxin C-fragment: the courier and the cure?. Toxins (Basel) 2 (2010), 2622–2644.
136. Tsukamoto, K., Kohda, T., Mukamoto, M., Takeuchi, K., Ihara, H., Saito, M., Kozaki, S., Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J. Biol. Chem. 280 (2005), 35164–35171.
137. Udwadia, F.E., Tetanus. 1994, Oxford University Press, Bombay.
138. Vale, R.D., The molecular motor toolbox for intracellular transport. Cell 112 (2003), 467–480.
139. van Ermengem, E., Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as “Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus” in Zeitschrift fur Hygiene und Infektionskrankheiten 26: 1-56, 1897. Rev. Infect. Dis. 1 (1979), 701–719.
140. Wade, A., Thomas, C., Kalmar, B., Terenzio, M., Garin, J., Greensmith, L., Schiavo, G., Activated leukocyte cell adhesion molecule modulates neurotrophin signaling. J. Neurochem. 121 (2012), 575–586.
141. Wang, T., et al. Flux of signalling endosomes undergoing axonal retrograde transport is encoded by presynaptic activity and TrkB. Nat. Commun., 7, 2016, 12976.
142. Wang, T., et al. Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a. J. Neurosci. 35 (2015), 6179–6194.
143. Weisemann, J., Stern, D., Mahrhold, S., Dorner, B.G., Rummel, A., Botulinum neurotoxin serotype a recognizes its protein receptor SV2 by a different mechanism than botulinum neurotoxin B synaptotagmin. Toxins (Basel), 8, 2016.
144. Wiegand, H., Erdmann, G., Wellhoner, H.H., 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedeb. Arch. Pharmacol. 292 (1976), 161–165.
145. Williamson, L.C., Fitzgerald, S.C., Neale, E.A., Differential effects of tetanus toxin on inhibitory and excitatory neurotransmitter release from mammalian spinal cord cells in culture. J. Neurochem 59 (1992), 2148–2157.
146. Williamson, L.C., Bateman, K.E., Clifford, J.C., Neale, E.A., Neuronal sensitivity to tetanus toxin requires gangliosides. J. Biol. Chem. 274 (1999), 25173–25180.
147. Yao, G., Lee, K., Gu, S., Lam, K.H., Jin, R., Botulinum neurotoxin A complex recognizes host carbohydrates through its hemagglutinin component. Toxins (Basel) 6 (2014), 624–635.
148. Yeh, F.L., Dong, M., Yao, J., Tepp, W.H., Lin, G.Y., Johnson, E.A., Chapman, E.R., SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog., 6, 2010, e1001207.
149. Zanetti, G., Azarnia Tehran, D., Pirazzini, M., Binz, T., Shone, C.C., Fillo, S., Lista, F., Rossetto, O., Montecucco, C., Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism. Biochem. Pharmacol. 98 (2015), 522–530.
150. Zhang, S., et al. Identification and characterization of a novel botulinum neurotoxin. Nat. Commun., 8, 2017, 14130.
151. Zhang, Y., Varnum, S.M., The receptor binding domain of botulinum neurotoxin serotype C binds phosphoinositides. Biochimie 94 (2012), 920–923.